US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street JournalB
BNTX
BIONTECH
111.93
-0.83-0.74%Pre Market: 112.17 +0.24 +0.21%08:53 01/21 EST
OPEN/PREV CLOSE113.56/112.76
TODAY RANGE111.93-114.67
VOL229
MARKET CAP26.83B
52 WEEK RANGE76.53-131.49
AVG VOL (3M)825.66K
% TURNOVER0.19%
TURNOVER0
P/E (TTM)-51.4172
% RANGE2.43%
EPS(TTM)-2.1769
P/E(FORWARD)-36.1788
P/B1.260
BVPS88.81
DIVIDEND--
P/S6.31
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP10.28B
SHARES OUTSTANDING239.74M
NEXT EARNINGS--
FREE FLOAT91.82M
LOT SIZE1
EX-DIV DATE06/02/2022
News
Press Releases
Financial Reports
Profile
TipRanks·58m ago
Morgan Stanley Sticks to Its Buy Rating for BioNTech SE (BNTX)
TipRanks·7h ago
Berenberg Bank Remains a Buy on BioNTech SE (BNTX)
Seeking Alpha·5d ago
Moderna's Road To Stopping The Red
Simply Wall St·6d ago
BioNTech SE (NASDAQ:BNTX) Investors Are Less Pessimistic Than Expected
TipRanks·6d ago
Truist Financial Issues a Buy Rating on BioNTech SE (BNTX)
TipRanks·01/14 12:17
BioNTech Unveils 2025 Strategic Priorities and Pipeline Progress
TipRanks·01/14 11:55
BioNTech provides business and pipeline updates
Seeking Alpha·01/13 23:10
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
Benzinga·01/13 16:06
Why BioNTech (BNTX) Shares Are Volatile Today
TipRanks·01/13 13:17
Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX)
Benzinga·01/10 19:54
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Dow Jones·01/10 10:20
BioNTech Price Target Announced at $172.00/Share by Truist Securities
Dow Jones·01/10 10:20
BioNTech Initiated at Buy by Truist Securities
Same Industry
Name/Symbol
Change%
Price